Insiders · Profile

Ezekowitz Alan

Director at Fulcrum Therapeutics · Director at Septerna. Filing since 4 Mar 2025. CIK 0001780209

Company
Date
Role
Action
Shares
Amount
Of holding
26 Jun 2026
Director
Sold at will
18,000
$65.61K
62.2%
7 Mar 2025
Director
Bought
13,319
$92.27K
12.8%
6 Mar 2025
Director
Bought
41,355
$248.13K
65.9%
5 Mar 2025
Director
Bought
37,835
$220.26K
152%
4 Mar 2025
Director
Bought
7,491
$47.54K
43.0%
5 decisions on file.